How Jim Simons Built the World’s Most Lucrative Black Box (Bloomberg) Anyone looking to learn how a quant fund conquered the financial world should......
(read more)November 1 - Hedge Funds, Insider Trading - Comments
Ray Dalio Sees 25% Chance of Recession This Year and in 2020 (Bloomberg) Ray Dalio, the billionaire founder of the world’s largest hedge fund, said......
(read more)September 5 - Hedge Funds, Insider Trading - Comments
Quantitative funds are gaining more ground among hedge funds in terms of trading volume and inflow of capital. According to The Wall Street Journal, this......
(read more)December 28 - Hedge Funds, News, Quantitative Investing - Comments
1. U.S. Stock Market: “U.S. stocks rose on Monday, boosted by technology shares and by defense companies, which rose after the United States and......
(read more)May 22 - Commodities, Futures/Forex, Gold, Market Movers, News, Tech - Comments
How To Become A Successful Investor? Being a successful investor is difficult. The market can be very random and completely irrational much of the time......
(read more)March 26 - Lists, News - Comments
At the end of last week, Amgen, Inc. (NASDAQ:AMGN) announced some data from its large-scale trial of its cardiovascular risk asset Repatha. The drug first......
(read more)March 20 - News, Stock Analysis - Comments
Although all three major indexes have rebounded into the green this afternoon, shares of five companies, Amgen, Inc. (NASDAQ:AMGN), Esperion Therapeutics......
(read more)March 17 - Market Movers, News - Comments
As a healthcare-focused fund, Michael Castor‘s Sio Capital registered a terrible 2016, as it lost 18.7% net, compared to the 12% gain registered......
(read more)March 3 - Hedge Fund Investor Letters, Hedge Funds, News - Comments
By Khojinur Usmonov From low costs to expedited drug approval, President Trump recently met with big pharma CEOs about overhauling the entire system.......
(read more)February 23 - News, Stock Analysis - Comments
Correction: A previous version of this article erroneously presented older events about the case between Sanofi/Regeneron and Amgen. The article has......
(read more)February 9 - News, Stock Analysis - Comments
Etelcalcetide, an Amgen, Inc. (NASDAQ:AMGN) drug that is meant to treat secondary hyperparathyroidism has been approved by the U.S. Food and Drug Administration......
(read more)February 8 - News, Stock Analysis - Comments
Esperion Therapeutics Inc (NASDAQ:ESPR) picked up strength at the end of last week, on the back of some news that – at first glance – seems unrelated......
(read more)February 7 - News, Stock Analysis - Comments
What does 2017 hold for Amgen, Inc. (NASDAQ:AMGN) and can this pharmaceutical stock lend color to your equity portfolio? Here’s a look at what makes......
(read more)January 23 - News, Stock Analysis - Comments
After a strong 2015, health care stocks are leading the way lower in 2016. And it’s been an even uglier year for biotechnology company Gilead Sciences......
(read more)December 23 - News, Stock Analysis - Comments
Michael Burry is one of the most well known hedge fund managers outside finance circles. Here is what we said about him in our previous article: “......
(read more)November 30 - Hedge Funds - Comments
Third Avenue Management is a New York-based investment fund that uses a deep value investing strategy for stock selection. The fund was founded by Martin......
(read more)October 29 - Hedge Fund Investor Letters, Hedge Funds, News - Comments
All three indexes are in the green today after U.S. consumer confidence jumped to its highest figure in nine years during September. According to the......
(read more)September 27 - Market Movers, News - Comments
Romosozumab (AKA romo) from Amgen Inc (NASDAQ:AMGN) and Belgium-based UCB, which is in its Phase III FRAME study is yet to achieve any regulatory approval......
(read more)September 20 - News, Stock Analysis - Comments
Coherus Biosciences Inc (NASDAQ:CHRS) submitted a biologics licensing application (BLA) for its lead biosimilar development candidate earlier this month......
(read more)August 16 - News, Stock Analysis - Comments
Given that it’s the middle of earnings season, it’s not surprising that many major companies are trending today. The market are in the red......
(read more)July 28 - Earnings Report, News - Comments
The biosimilar space is relatively young. Only across the last handful of of years has the FDA put firm regulatory processes in place for the approval......
(read more)July 12 - News, Stock Analysis - Comments
Paul Holland and Matthew Miller co-founded Glaxis Capital in 2005. The fund’s equity portfolio has remained fairly concentrated since the end of......
(read more)May 16 - Hedge Funds, News, Tech - Comments
The ten S&P 500 companies that have increased their dividend payout by the highest average annual rate during the last five years are analyzed in......
(read more)May 6 - Dividend Stocks, News, Stock Analysis - Comments
There are various reasons why corporate insiders might sell shares of their own companies. For instance, they may seek to diversify their holdings, buy......
(read more)May 4 - Dividend Stocks, Insider Trading, News - Comments
Billionaire Daniel S. Loeb founded activist hedge fund Third Point LLC in 1995. The $17 billion New York-based firm lost 1.4% in 2015, which was not necessarily......
(read more)April 24 - Dividend Stocks, Hedge Fund Analysis, Hedge Funds, News - Comments
Biotech has undoubtedly been one of the most cherished industries, among hedge funds over the last few years and it’s not hard to understand why......
(read more)December 20 - Hedge Funds, News - Comments
With crude futures failing to rally past a key technical resistance level, shares of Sunedison Inc (NYSE:SUNE), SolarCity Corp (NASDAQ:SCTY),Solaredge......
(read more)December 16 - Market Movers, News - Comments
Billionaire activist investor Dan Loeb of Third Point saw his hedge fund post losses of 8.9% for the September quarter in comparison to the S&P 500......
(read more)November 19 - Hedge Fund Analysis, Hedge Funds, News - Comments
Billionaire investor Dan Loeb, the founder of activist hedge fund Third Point LLC, discussed the performance of his investment firm, including the broader......
(read more)November 16 - Hedge Fund Analysis, Hedge Funds, Macroeconomic Predictions, News - Comments
Sivik Global Healthcare is a Greenwich, Connecticut-based healthcare-focused hedge fund founded by Krishen Sud in 2006. In 2011, the fund merged with......
(read more)November 9 - Hedge Fund Analysis, Hedge Funds, News - Comments
When it comes to activist investing, Dan Loeb is one of the best in the business, generating strong returns through pushing companies to implement changes......
(read more)November 3 - Hedge Funds, News, Tech - Comments
When it rains, it pours, and for big pharma, it certainly poured in the third quarter. With the third quarter over, let’s take a closer look at ......
(read more)October 20 - Hedge Funds, News - Comments
One of the best ways to pick high-performing stocks is to follow the industry leaders and find out their stock investments. Today, we decided to cover......
(read more)June 25 - Hedge Funds, News - Comments
Famous billionaire activist hedge-fund manager Dan Loeb of Third Point is renowned for the bombshells that he drops on the management of his target companies......
(read more)May 21 - Hedge Funds, News - Comments
March Altus Capital Management, headquartered in Greenwich, Connecticut, was founded by Neil Shah in December 2011.This healthcare focused fund follows......
(read more)April 16 - Hedge Funds, News - Comments
Headquartered in Connecticut, Sarissa Capital Management was founded by Alexander J. Denner in 2012. Prior to this, Mr. Denner worked as a portfolio manager......
(read more)April 15 - Hedge Funds, News - Comments
Considering that the second-largest holding of Dan Loeb‘s Third Point, Alibaba Group Holding Ltd (NYSE:BABA), lost 19.92% of its stock value during......
(read more)April 8 - Hedge Funds, News - Comments
According to a Schedule 13D form filed yesterday with the Securities and Exchange Commission, Samuel Islay‘s Orbimed Advisors has slashed its stake......
(read more)March 26 - Hedge Funds, News - Comments
With the high volatility prevalent in the biotechnology sector, investors have a hard time picking the right stocks to invest in. Moreover, due to the......
(read more)February 23 - Hedge Funds, News - Comments
Alex Denner’s Sarissa Capital Management recently disclosed its stock picks for the fourth quarter of 2014 in a 13F Form filed with the U.S. Securities......
(read more)February 21 - Hedge Funds, News - Comments
Dan Loeb`s Third Point filed its latest 13F with the SEC last week, detailing its long positions at the end of a self-admittedly poor year for the fund......
(read more)February 15 - Hedge Funds, News - Comments
Benjamin A. Smith’s Laurion Capital Management recently filed its 13F Form for last quarter with the U.S. Securities and Exchange Commission. Therein......
(read more)February 11 - Hedge Funds, News - Comments
The days of having no fund activity in Epirus Biopharmaceuticals Inc (NASDAQ:EPRS) are over. In filings with the SEC that were revealed over the last......
(read more)February 9 - Hedge Funds, News - Comments
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) has, once again, shown today why biopharmaceuticals companies are so popular with investors, especially......
(read more)October 17 - News - Comments
Shares of Amgen, Inc. (NASDAQ:AMGN), which are up almost 16% this year, were trending high in the early afternoon hours, gaining nearly 4% after a day......
(read more)August 14 - News - Comments
Amgen, Inc. (NASDAQ:AMGN) announced its second quarter financial results on July 29, 2014. Amgen’s total revenues increased by 11% on the year......
(read more)July 30 - Earnings Report, News - Comments
Commenting on the market movements, CNBC reporter Bob Pisani gave a brief on the latest trends in the market and the sectors which are on a high in the......
(read more)June 23 - Market Movers, News - Comments
New York City-based Iguana Healthcare Management was founded by Stuart Weisbrod in 2010. The fund invests in pharmaceuticals, biotechnology, medical devices......
(read more)February 25 - Hedge Funds, News - Comments
Over the past few years at StreetAuthority, we’ve been chronicling the remarkable pace of share buybacks. So many companies are buying back $500......
(read more)September 19 - ETF Trading, News - Comments
